# Bespoke Gene Therapy Consortium Coordination Center (BGTC CC) Electronic Data Capture (EDC) Platform Support

Canonical: https://abierto.us/opportunities/hhsn316201500008w75n95025f00001

- Solicitation number: HHSN316201500008W75N95025F00001
- Notice type: Justification (first published as award notice)
- Status: Awarded to Iqvia Government Solutions Inc. for $5,596,917.66
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nida (75N950)
- NAICS: 334111 Electronic Computer Manufacturing
- Product or service code: 7H20 Hardware, software, and other equipment needed for local database instances, distributed platform, application and system integration resources enabling cross application development, communications and information sharing. Includes Mainframe database and middleware products and tools.
- Place of performance: Falls Church, Virginia
- County: Fairfax County (FIPS 51059). https://abierto.us/counties/fairfax-county-va-51059
- First posted: November 21, 2024
- Last posted: November 21, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/ed2d3f4ce3e94707a8d75c5f7f54e645/view

## Description

The objective of this acquisition is to obtain cloud platform services to support data collection, dissemination, analysis, integration, reporting, and management of the BGTC. The BGTC is part of the Accelerating Medicines Partnership (AMP) program, a public–private partnership among NIH, the U.S. Food and Drug Administration (FDA), multiple pharmaceutical and life sciences companies, and nonprofit and other organizations.

The AMP program, which is managed by the Foundation for the NIH (FNIH), aims to improve current models for developing diagnostics and therapies. NCATS is the lead NIH IC for BGTC, one of several NCATS-led programs aligned with the NCATS’ mission to re-engineer the translational research process so new treatments and cures for diseases can be delivered to patients faster.

The BGTC is establishing platforms and standards to speed the development and delivery of customized or “bespoke” gene therapies (GT) that could treat millions of people affected by rare diseases, including diseases too rare to be of commercial interest.

## Award on USAspending

- Recipient: Iqvia Government Solutions Inc. (UEI T13YR5E14QY7)
- Contract: HHSN316201500008W
- Obligated: -$250.00
- Competition: Full and Open Competition, 7 offers received
- Link: award number HHSN316201500008W equals the contract number; same sub-agency 7529 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_HHSN316201500008W_7529/


## Publications

- November 21, 2024: Award notice. Notice 55d9ead993374cc6ace65d293763da1a. https://sam.gov/workspace/contract/opp/55d9ead993374cc6ace65d293763da1a/view
- November 21, 2024: Justification. Notice ed2d3f4ce3e94707a8d75c5f7f54e645. https://sam.gov/workspace/contract/opp/ed2d3f4ce3e94707a8d75c5f7f54e645/view

## Points of contact

- Maggie Brant, maggie.brant@nih.gov, 3018271771
- KJ Shaikh, KJ.Shaikh@nih.gov, 3014351777

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/hhsn316201500008w75n95025f00001.